NIPPON-SHOKUBAI
31.5.2022 02:46:13 CEST | Business Wire | Press release
Nippon Shokubai and Arkema are joining forces to launch feasibility studies and establish a joint venture for the construction of an industrial plant for the production of LiFSI (Lithium bis(fluorosulfonyl)imide) ultrapure electrolyte salt, a key component of battery cells for electric mobility.
Ultrapure and high performance LiFSI electrolyte salts, a key component of car battery cells, will speed up the development of new electrolyte formulations for the next generations of batteries, including semi-solid and solid state batteries, by significantly increasing their power, stability, cycle life, and recyclability, while reducing charging time in high or low temperature conditions.
This industrial project will support the development of the European battery value chain and participate in the global need for carbon-neutral mobility.
Combining Arkema’s fluorochemicals expertise and Nippon Shokubai’s unique know-how in the industrial-scale production of high-purity LiFSI, both partners have joined forces in a strategic partnership that has led to the development of an innovative and integrated process. Based on this cutting-edge patented technology, a LiFSI pilot production line has been installed on the Pierre-Bénite site and successfully came on stream in 2021.
To support the exponential growth in demand for battery cell materials, Arkema and Nippon Shokubai are taking a step forward by launching feasibility studies and establishing a joint venture to enable the mass-production of LiFSI electrolyte salt at Arkema’s Pierre-Bénite site in France by end 2025.
About Nippon Shokubai:
Since 1941, Nippon Shokubai has grown up its business with unique catalyst technology. Nippon Shokubai has supplied, for example, ethylene oxide, acrylic acid, automobile catalysts, process catalysts and so on. Among all, our global market share of superabsorbent polymers is the largest in the world now (according to Nippon Shokubai research). Nippon Shokubai is a global chemical company operating under its corporate mission "TechnoAmenity – Providing prosperity and comfort to people and society, with our unique technology."
About Arkema:
Building on its unique set of expertise in materials science, Arkema offers a portfolio of first-class technologies to address ever-growing demand for new and sustainable materials. With the ambition to become in 2024 a pure player in Specialty Materials, the Group is structured into 3 complementary, resilient and highly innovative segments dedicated to Specialty Materials -Adhesive Solutions, Advanced Materials, and Coating Solutions- accounting for some 85.5% of Group sales in 2021, and a well-positioned and competitive Intermediates segment. Arkema offers cutting-edge technological solutions to meet the challenges of, among other things, new energies, access to water, recycling, urbanization and mobility, and fosters a permanent dialogue with all its stakeholders. The Group reported sales of around €9.5 billion in 2021, and operates in some 55 countries with 20,200 employees worldwide.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220526005413/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Experian Recognized by Chartis Research for Advancing AI Model Governance in Quantitative Analytics50 202629.7.2026 15:00:00 CEST | Press release
Global data and technology company recognized for helping financial institutions accelerate AI innovation with trusted model governance, transparency and regulatory control Key Highlights Chartis Research recognized Experian as the category winner for Model Risk Management Environment in the Quantitative Analytics50 2026 report. Experian Ascend Platform™ enables organizations to move from model development to governed production with transparency, traceability and policy-driven controls. Recognition validates Experian's approach to helping lenders and financial institutions accelerate AI adoption while strengthening compliance, explainability and model risk governance. Experian today announced it has been recognized by Chartis Research as the winner in the Model Risk Management Environment category in the Quantitative Analytics50 2026 report. The recognition marks Experian's first appearance in the prestigious ranking and reinforces the company's position as a leading provider of data
Grid Dynamics Accelerates Enterprise AI-Native Transformation With Workforce Certification and GAIN Platforms Rollout29.7.2026 15:00:00 CEST | Press release
Key Takeaways: Grid Dynamics plans to have 90% of its engineers trained and certified on Anthropic and OpenAI platforms by the end of October 2026. At one of North America's largest home improvement retailers, Grid Dynamics has scaled its GAIN (Grid Dynamics AI Native) Platform for AI SDLC by expanding its agentic harness technology to more than 500 additional engineers. Grid Dynamics Holdings, Inc. (Nasdaq: GDYN) (“Grid Dynamics”), a leading provider of technology consulting, platform and product engineering, and AI-driven digital transformation services, today announced significant momentum in the adoption of its enterprise agentic AI solutions. Organizations across retail, financial services, manufacturing, CPG, and logistics industries are increasingly deploying Grid Dynamics’ agentic AI-native platforms and Forward Deployed Engineering (FDE)-led services to accelerate software delivery, improve operational efficiency, and transform business processes at scale. Grid Dynamics is wid
VDyne Announces First Patient Treated in TRIVITA US IDE Pivotal Study of the TriNova™ Transcatheter Tricuspid Valve Replacement System29.7.2026 15:00:00 CEST | Press release
VDyne Inc. (“VDyne”), a privately held medical device company developing an innovative transcatheter tricuspid valve replacement (TTVR) system, today announced that the first patient has been enrolled and treated in the TRIVITA US IDE pivotal study of the TriNova™ system. The randomized controlled study will compare TriNova head-to-head with the commercially available Edwards EVOQUE™ TTVR system. The TRIVITA trial (NCT07516444) initiation marks a significant milestone in advancing treatment for tricuspid regurgitation (TR). The prospective, global, multicenter, randomized (1:1) controlled study is designed to evaluate the safety and effectiveness of the TriNova TTVR system in patients with severe or greater tricuspid regurgitation who are suitable for valve replacement. The study will be conducted in the US and Europe with up to 70 sites participating. The first patient was enrolled at the Allina Health Minneapolis Heart Institute at Abbott Northwestern Hospital in Minneapolis, and tre
New Continuous Delivery Loop Framework From Coherent Solutions Closes the AI Value Gap for Software Engineering Teams Moving From AI-Assisted to AI-Native Development29.7.2026 15:00:00 CEST | Press release
The company's early results show an approximately 30% delivery-performance gain when AI tool adoption is paired with operating model change Software teams are generating code faster than ever with AI, yet many see the bottleneck shifting to delivery speed and code quality. Coherent Solutions, a global digital engineering firm, argues in its recent whitepaper that the problem lies in traditional SDLC processes that aren't built for AI's speed. It introduces an operating framework designed to close that gap, called the Continuous Delivery Loop (CDL). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260729426213/en/ New Continuous Delivery Loop framework from Coherent Solutions The whitepaper, “From traditional SDLC to the Continuous Delivery Loop,” is available to download for free. The whitepaper also describes what the company calls the "Digital Value Gap," which exists between accelerated developer activity and actual busines
Arendt Launches AVA, Its Proprietary AI-powered Prospectus Compliance Review Tool29.7.2026 14:54:00 CEST | Press release
Arendt & Medernach, the leading independent Luxembourg-based law firm specialising in business law, investment funds, corporate law and tax, announced the launch of AVA (Arendt Visa Agent), a proprietary, purpose-built AI solution designed for UCITS prospectus compliance review. Developed in-house and built on Arendt's own legal knowledge and methodology, with the technical architecture delivered in close collaboration with a specialist AI technology partner, AVA marks a key milestone in Arendt's innovation strategy and reinforces its commitment to leveraging advanced technology to support its clients. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260729264434/en/ The scale of the challenge Arendt has developed AVA, an AI-driven compliance tool that draws on the firm's unparalleled market intelligence in UCITS – built over decades of advising fund managers, boards and service providers on Luxembourg's most complex prospectu
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom